Clinical trials
Cholangiocarcinoma trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Terminated | 3 |
| Completed | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 3 |
| PCI Biotech AS | 2 |
| AstraZeneca | 1 |
| Boston Scientific Corporation | 1 |
| Fore Biotherapeutics | 1 |
| Incyte Corporation | 1 |
| Maastricht University | 1 |
| Maastricht University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 11 |
| Bile Duct Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
| Biliary Tract Neoplasms | 2 |
| Klatskin Tumor | 2 |
| Breast Neoplasms | 1 |
| Cholangitis, Sclerosing | 1 |
| Colorectal Neoplasms | 1 |
| Fallopian Tube Neoplasms | 1 |
| Gallbladder Neoplasms | 1 |
Trials
Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.